Literature DB >> 6277981

Reduced Na+, K+ -ATPase activity in intact red cells and isolated membranes from obese man.

I Klimes, M Nagulesparan, R H Unger, S L Aronoff, D M Mott.   

Abstract

Na+, K+ -ATPase activity was measured in red blood cells from 20 nondiabetic euthyroid male Pima Indians with varying degrees of obesity; their body mass indices ranged from 22-60 kg/m2. The na+, K+ -ATPase, measured both by 86Rb uptake in intact cells and ATP hydrolysis by purified membranes, was inversely correlated with body mass index (r = -0.62; P less than 0.005 and r = -0.75; P less than 0.0001, respectively). These results confirm that obesity is associated with decreased Na+, K+ -ATPase in intact red blood cells, and provide the first demonstration of a reduced sodium pump in isolated red cell membrane preparations from obese men.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277981     DOI: 10.1210/jcem-54-4-721

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  DNA variation in the genes of the Na,K-adenosine triphosphatase and its relation with resting metabolic rate, respiratory quotient, and body fat.

Authors:  O Dériaz; F Dionne; L Pérusse; A Tremblay; M C Vohl; G Côté; C Bouchard
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

2.  Leucocyte sodium pump activity after meals or insulin in normal and obese subjects: cause for increased energetic efficiency in obesity?

Authors:  L L Ng; M A Bruce; T D Hockaday
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-28

3.  Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.

Authors:  M Modan; H Halkin; S Almog; A Lusky; A Eshkol; M Shefi; A Shitrit; Z Fuchs
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

4.  Red blood cell aggregation and deformability among patients qualified for bariatric surgery.

Authors:  Maciej Wiewiora; Krystyn Sosada; Mariusz Wylezol; Ludmila Slowinska; Wojciech Zurawinski
Journal:  Obes Surg       Date:  2007-03       Impact factor: 3.479

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.